Researchers have developed a computational model for human MEK1, a protein with potential as a drug target for a variety of human cancers. This insight into the previously unknown structure of MEK1 opens the door to the development of new classes of inhibitors.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023